Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence

Patria (Recombinant NDV Vectored Vaccine for SARS-CoV-2) - National Autonomous University of Mexico, Avimex, Mexican Social Security Institute

http://clinicaltrials.gov/ct2/show/NCT05205746

Sep 28, 2022